Winvest Group and BioCalth Form Strategic Partnership
Winvest Group Limited (OTCQB: WNLV) has made significant strides by forming a strategic partnership between its subsidiary, IQI Media Inc., and BioCalth International Inc. The collaboration aims to accelerate BioCalth’s direct-to-consumer sales initiative, marking an exciting development for both companies. By harnessing IQI Media's expertise in content management and digital marketing strategies, they plan to elevate BioCalth's brand visibility in the health supplement sector.
Agreement Details for Increased Revenue
The partnership is structured around a content management agreement that includes profit-sharing components, creating opportunities for sustained growth. This agreement establishes a framework for a long-term collaboration that not only enhances revenue streams but also strengthens brand recognition for BioCalth. Under this arrangement, IQI Media will receive a fixed monthly retainer in addition to a share of the profits when the total net revenue from sales exceeds $30,000, moving towards a target of over $1 million.
BioCalth's Legacy and Market Presence
With a history spanning over 25 years, BioCalth has firmly established itself as a leader in the health supplement industry. Their manufacturing processes utilize patented products to ensure quality and efficacy, all produced domestically while being disseminated globally. Khiow Hui Lim, the Founder of IQI Media, expressed enthusiasm for assisting BioCalth in launching their new e-commerce platform that will bring their innovative products, particularly the calcium L-threonate, to a broader consumer base.
Product Launch and Marketing Strategy
The introduction of calcium L-threonate marks a pivotal moment in BioCalth's market strategy. To ensure the product reaches health-conscious consumers effectively, IQI Media will implement a top-of-funnel strategy focusing on social media marketing. This approach aims to create awareness and build trust with potential customers, signaling a commitment to promoting quality health solutions backed by scientific evidence.
Laboratory Research and Product Development
BioCalth’s commitment to research is evident in their partnership with reputable institutions; substantial laboratory research conducted at UCLA confirms that their calcium L-threonate formula boasts a remarkable 95% absorption rate, demonstrating its superior efficiency compared to other calcium supplements available. Jackson Wen, the Founder of BioCalth, emphasizes how the partnership with IQI Media will enhance outreach and education around their scientifically validated products.
Expansion of Manufacturing Capabilities
Beyond direct-to-consumer sales, BioCalth is also focused on expanding its manufacturing capabilities at its cutting-edge facility. This expansion is crucial as the company seeks to offer manufacturing services to a range of other companies within the pharmaceutical and nutritional supplement sectors. BioCalth's facility holds FDA registration and is GMP-certified, ensuring their operations adhere to the highest safety standards to maintain their growing reputation in the biotechnology space.
Vision for Future Growth
Sophia Li, VP of Marketing at BioCalth, highlighted that this phase of expansion integrates enhanced sales capabilities, sophisticated data analytics, and streamlined backend management. This strategy is pivotal for sustaining BioCalth's growth momentum, ensuring they continue to lead in both product innovation and manufacturing excellence.
About IQI Media
IQI Media Inc., based in Los Angeles, California, focuses on producing and managing original content while delivering strategic content marketing services aimed at data-driven growth for clients. As a subsidiary of Winvest Group Limited, IQI Media continues to champion innovative approaches in media and technology, reinforcing their position as a forward-thinking entity in the industry.
About Winvest Group
Winvest Group Limited is dedicated to diversifying its investment across various sectors, including media, entertainment, and technology. Currently trading under the ticker WNLV on the OTC Markets, the company is actively pursuing growth opportunities with plans to move toward an IPO and listing on Nasdaq in the near future, positioning itself for greater visibility and access to capital.
Frequently Asked Questions
What is the main purpose of the Winvest and BioCalth partnership?
The partnership aims to enhance BioCalth's direct-to-consumer sales and brand recognition through effective marketing strategies and content management by IQI Media.
How will the profit-sharing structure work?
IQI Media will receive a fixed monthly retainer and a percentage of profits once total net revenue from BioCalth’s sales exceeds $30,000.
What product is BioCalth launching with this partnership?
BioCalth is launching calcium L-threonate, their flagship product known for its high absorption rate.
Where is BioCalth's manufacturing facility located?
BioCalth operates a state-of-the-art manufacturing facility that is FDA-registered and GMP-certified in California.
What are Winvest Group's plans for the future?
Winvest Group plans to pursue an IPO and upgrade its listing to Nasdaq, aiming for greater growth and visibility in the market.
